Unit Biotech & ATMP’s

GMP facility for the production of investigational drugs based on biotechnological processes and cellular therapies Facility
The Unit Biotech & ATMP’s is expert in the translation of new innovative drugs to a GMP production process. It manufactures Active Pharmaceutical Ingredients (API) and finished Investigational Medicinal Products (IMP) according to the GMP legislation.

We facilitate technical transfer and small scale productions based on biotechnological processes and the production of ATMP’s (Advanced Therapy Medicinal Products). ATMP’s are medicinal products based on genes, cells and/or tissues.

The facility produces different types of biologicals

  • recombinant proteins from bacterial or yeast cell lines
  • medicinal products based on cells or tissues
  • fluorescent labelling of antibodies for imaging studies

The services we offer

  • We produce biologicals and cell based products for research groups within the UMCG/ RuG,  academic hospitals, and companies who focus on the development and production of biotechnological drugs or ATMP’s.

  • We support researchers to translate their preclinical findings into a process that meets the GMP standards.